An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
Day 2, 11th August 2019
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A randomized controlled trial of hyperbaric oxygen to prevent osteo radionecrosis of the irradiated mandible after dentoalveolar surgery
Reviewer : Gagan Saini
Eating As Treatment (EAT): A stepped-wedge, randomized controlled trial of a health behavior change intervention provided by dietitians to improve nutrition in patients with head and neck cancer under going radiation therapy (TROG 12.03)
Reviewer : Y. T. Shivashankar
PO-1019 HDR interstitial brachytherapy in recurrent head and neck cancer: An effective salvage option
Reviewer : Vibhay Pareek
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients
Reviewer : Vivek Agarwala
Burden of acute toxicities in head-and-neck radiation therapy: A single-institutional experience
Reviewer : Pranav Chadha
Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy
Reviewer : Priti Arolkar
Prognostic value of response assessment fluorodeoxyglucose positron emission tomography-computed tomography scan in radically treated squamous cell carcinoma of head and neck: Long-term results of a prospective study
Reviewer : Madhuri Shimpi
Humanpapillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region
Reviewer : Bijal Kulkarni
Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in oral cavity cancers
Reviewer : M. V. Chandrakanth
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study
Reviewer : Vikas Talreja
TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line RecurrenVMetastatic Head and Neck Squamous Cell Carcinoma (RIM HNSCC)
Reviewer : Avinash Pandey
Palbociclib plus Cetuximab versus placebo plus Cetuximab in platinum resistant, Cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS)
Reviewer : Nikhil Pande